ZFP36 | ZFP36 ring finger protein | 19q13.1 | 0.612 | 0.805 | 0
|
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 12q13 | 0.533 | 0.737 | 0
|
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 19q13.3 | 0.528 | 0.716 | 0
|
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 9q22 | 0.511 | 0.688 | 0
|
SOCS3 | suppressor of cytokine signaling 3 | 17q25.3 | 0.505 | 0.74 | 0
|
ATF3 | activating transcription factor 3 | 1q32.3 | 0.488 | 0.727 | 0
|
EGR1 | early growth response 1 | 5q23-q31 | 0.478 | 0.733 | 0
|
EGR3 | early growth response 3 | 8p23-p21 | 0.476 | 0.699 | 0
|
CYR61 | cysteine-rich, angiogenic inducer, 61 | 1p22.3 | 0.471 | 0.688 | 0
|
FOS | FBJ murine osteosarcoma viral oncogene homolog | 14q24.3 | 0.463 | 0.713 | 0
|
C11orf96 | chromosome 11 open reading frame 96 | 11p11.2 | 0.463 | 0.674 | 0
|
GPR183 | G protein-coupled receptor 183 | 13q32.3 | 0.442 | 0.637 | 0
|
IL6 | interleukin 6 | 7p15.3 | 0.44 | 0.644 | 0
|
CSRNP1 | cysteine-serine-rich nuclear protein 1 | 3p22 | 0.439 | 0.658 | 0
|
CTGF | connective tissue growth factor | 6q23.2 | 0.424 | 0.645 | 0
|
RGS2 | regulator of G-protein signaling 2 | 1q31 | 0.422 | 0.655 | 0
|
JUN | jun proto-oncogene | 1p32-p31 | 0.412 | 0.669 | 0
|
KLF9 | Kruppel-like factor 9 | 9q21.11 | 0.401 | 0.643 | 0
|
MYADM | myeloid-associated differentiation marker | 19q13.42 | 0.401 | 0.549 | 0
|
ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 10q25.1 | 0.397 | 0.604 | 0
|
PER1 | period circadian clock 1 | 17p13.1 | 0.391 | 0.629 | 0
|
RASD1 | RAS, dexamethasone-induced 1 | 17p11.2 | 0.391 | 0.612 | 0
|
CXCL2 | chemokine (C-X-C motif) ligand 2 | 4q13.3 | 0.378 | 0.625 | 0
|
RGS1 | regulator of G-protein signaling 1 | 1q31 | 0.37 | 0.601 | 0
|
HBEGF | heparin-binding EGF-like growth factor | 5q23 | 0.366 | 0.637 | 0
|
SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 | 12p13.31 | 0.36 | 0.486 | 0
|
JUNB | jun B proto-oncogene | 19p13.13 | 0.36 | 0.57 | 0
|
FPR1 | formyl peptide receptor 1 | 19q13.41 | 0.343 | 0.465 | 0
|
STC1 | stanniocalcin 1 | 8p21.2 | 0.34 | 0.493 | 0
|
KLF2 | Kruppel-like factor 2 | 19p13.11 | 0.332 | 0.555 | 0
|
TSC22D3 | TSC22 domain family, member 3 | Xq22.3 | 0.325 | 0.569 | 0
|
GADD45B | growth arrest and DNA-damage-inducible, beta | 19p13.3 | 0.323 | 0.603 | 0
|
PRDM1 | PR domain containing 1, with ZNF domain | 6q21 | 0.323 | 0.498 | 0
|
CD69 | CD69 molecule | 12p13 | 0.32 | 0.577 | 0
|
SDPR | serum deprivation response | 2q32-q33 | 0.32 | 0.517 | 0
|
RRAD | Ras-related associated with diabetes | 16q22 | 0.319 | 0.498 | 0
|
OSM | oncostatin M | 22q12.2 | 0.318 | 0.51 | 0
|
PLK3 | polo-like kinase 3 | 1p34.1 | 0.316 | 0.499 | 0
|
IER3 | immediate early response 3 | 6p21.3 | 0.314 | 0.543 | 0
|
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 20q13.1 | 0.311 | 0.433 | 0
|
SPRY1 | sprouty RTK signaling antagonist 1 | 4q | 0.31 | 0.471 | 0
|
SGK1 | serum/glucocorticoid regulated kinase 1 | 6q23 | 0.307 | 0.521 | 0
|
FAS | Fas cell surface death receptor | 10q24.1 | 0.301 | 0.433 | 0
|
G0S2 | G0/G1 switch 2 | 1q32.2 | 0.3 | 0.428 | 0
|
CSRP1 | cysteine and glycine-rich protein 1 | 1q32 | 0.3 | 0.442 | 0
|
RND3 | Rho family GTPase 3 | 2q23.3 | 0.299 | 0.471 | 0
|
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 7q22.1 | 0.299 | 0.464 | 0
|
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 21q21.3 | 0.296 | 0.476 | 0
|
NFIL3 | nuclear factor, interleukin 3 regulated | 9q22 | 0.295 | 0.485 | 0
|
ZNF436-AS1 | ZNF436 antisense RNA 1 | 1p36.12 | 0.293 | -0.472 | 0
|
NCOA5 | nuclear receptor coactivator 5 | 20q13.12 | 0.293 | -0.419 | 0
|
MEF2D | myocyte enhancer factor 2D | 1q12-q23 | 0.291 | 0.475 | 0
|
PRR5L | proline rich 5 like | 11p13-p12 | 0.287 | 0.261 | 5.23e-08
|
RHOB | ras homolog family member B | 2p24 | 0.286 | 0.507 | 0
|
ZNF74 | zinc finger protein 74 | 22q11.2 | 0.283 | -0.509 | 0
|
RGCC | regulator of cell cycle | 13q14.11 | 0.282 | 0.513 | 0
|
MCL1 | myeloid cell leukemia 1 | 1q21 | 0.282 | 0.494 | 0
|
FOXC2 | forkhead box C2 | 16q24.1 | 0.282 | 0.365 | 8.14e-15
|
PMS2P3 | PMS1 homolog 2, mismatch repair system component pseudogene 3 | 7q11.23 | 0.282 | -0.382 | 1.07e-16
|
RBM4B | RNA binding motif protein 4B | 11q13 | 0.281 | -0.443 | 0
|
CFLAR | CASP8 and FADD-like apoptosis regulator | 2q33-q34 | 0.28 | 0.397 | 0
|
BDKRB2 | bradykinin receptor B2 | 14q32.1-q32.2 | 0.28 | 0.479 | 0
|
BHLHE40 | basic helix-loop-helix family, member e40 | 3p26 | 0.279 | 0.401 | 0
|
ADGRG3 | adhesion G protein-coupled receptor G3 | 16q13 | 0.278 | 0.438 | 0
|
KLF6 | Kruppel-like factor 6 | 10p15 | 0.275 | 0.545 | 0
|
TRIM25 | tripartite motif containing 25 | 17q23.1 | 0.272 | -0.308 | 1.01e-10
|
OSTM1 | osteopetrosis associated transmembrane protein 1 | 6q21 | 0.271 | 0.428 | 0
|
ANKRD23 | ankyrin repeat domain 23 | 2q11.2 | 0.27 | -0.382 | 1.17e-16
|
TSC22D1 | TSC22 domain family, member 1 | 13q14 | 0.27 | 0.419 | 0
|
SBDS | Shwachman-Bodian-Diamond syndrome | 7q11.22 | 0.27 | 0.352 | 9.12e-14
|
C22orf29 | chromosome 22 open reading frame 29 | 22q11.21 | 0.269 | -0.464 | 0
|
TOP3B | topoisomerase (DNA) III beta | 22q11.22 | 0.268 | -0.477 | 0
|
NAA40 | N(alpha)-acetyltransferase 40, NatD catalytic subunit | 11q13.1 | 0.267 | -0.445 | 0
|
DUSP5 | dual specificity phosphatase 5 | 10q25 | 0.266 | 0.493 | 0
|
UCP3 | uncoupling protein 3 (mitochondrial, proton carrier) | 11q13.4 | 0.266 | -0.337 | 1.12e-12
|
ZNF473 | zinc finger protein 473 | 19q13.33 | 0.265 | -0.451 | 0
|
AREG | amphiregulin | 4q13.3 | 0.264 | 0.462 | 0
|
MEN1 | multiple endocrine neoplasia I | 11q13 | 0.262 | -0.443 | 0
|
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 12q15 | 0.261 | 0.389 | 0
|
EDN1 | endothelin 1 | 6p24.1 | 0.26 | 0.395 | 0
|
ZNF2 | zinc finger protein 2 | 2q11.1 | 0.259 | -0.478 | 0
|
PARS2 | prolyl-tRNA synthetase 2, mitochondrial (putative) | 1p32.2 | 0.258 | -0.42 | 0
|
EWSR1 | EWS RNA-binding protein 1 | 22q12.2 | 0.257 | -0.394 | 0
|
ODF3L1 | outer dense fiber of sperm tails 3-like 1 | 15q23 | 0.256 | 0.469 | 0
|
SNORA71E | small nucleolar RNA, H/ACA box 71E | 20q11.23 | 0.256 | -0.47 | 0
|
PJA2 | praja ring finger 2, E3 ubiquitin protein ligase | 5q22.1 | 0.255 | 0.409 | 0
|
ZNF180 | zinc finger protein 180 | 19q13.2 | 0.255 | -0.429 | 0
|
HSPB8 | heat shock 22kDa protein 8 | 12q24.23 | 0.252 | 0.372 | 2.09e-15
|
ZNF572 | zinc finger protein 572 | 8q24.13 | 0.251 | -0.334 | 1.74e-12
|
TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 12p11.22 | 0.25 | 0.349 | 1.51e-13
|
SIK1 | salt-inducible kinase 1 | 21q22.3 | 0.25 | 0.387 | 0
|
PTCHD4 | patched domain containing 4 | 6p12.3 | 0.249 | 0.377 | 5.17e-16
|
CCDC142 | coiled-coil domain containing 142 | 2p13.1 | 0.248 | -0.418 | 0
|
KLF4 | Kruppel-like factor 4 (gut) | 9q31 | 0.247 | 0.487 | 0
|
DDX12P | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12, pseudogene | 12p13.31 | 0.245 | -0.443 | 0
|
ZNF696 | zinc finger protein 696 | 8q24.3 | 0.242 | -0.435 | 0
|
TRIM58 | tripartite motif containing 58 | 1q44 | 0.24 | 0.335 | 1.49e-12
|
KIAA0040 | KIAA0040 | 1q25.1 | 0.238 | 0.364 | 1.04e-14
|
AVPI1 | arginine vasopressin-induced 1 | 10q24.2 | 0.237 | 0.32 | 1.61e-11
|
C8orf4 | chromosome 8 open reading frame 4 | 8p11.2 | 0.237 | 0.286 | 2.17e-09
|
FAM46A | family with sequence similarity 46, member A | 6q14 | 0.234 | 0.371 | 2.17e-15
|
LOC150776 | | | 0.233 | -0.398 | 0
|
CYB561D1 | cytochrome b561 family, member D1 | 1p13.2 | 0.232 | -0.361 | 1.88e-14
|
MAVS | mitochondrial antiviral signaling protein | 20p13 | 0.232 | -0.278 | 6.15e-09
|
ZNF646 | zinc finger protein 646 | 16p11.2 | 0.231 | -0.298 | 3.87e-10
|
POLE | polymerase (DNA directed), epsilon, catalytic subunit | 12q24.3 | 0.231 | -0.417 | 0
|
ZFP36L2 | ZFP36 ring finger protein-like 2 | 2p22.3-p21 | 0.23 | 0.369 | 3.9e-15
|
HYLS1 | hydrolethalus syndrome 1 | 11q24.2 | 0.229 | -0.361 | 1.71e-14
|
UNC119B | unc-119 lipid binding chaperone B | 12q24 | 0.228 | -0.221 | 4.39e-06
|
TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 8p22-p21 | 0.228 | 0.309 | 7.99e-11
|
PDE4D | phosphodiesterase 4D, cAMP-specific | 5q12 | 0.228 | 0.359 | 2.48e-14
|
DUSP8 | dual specificity phosphatase 8 | 11p15.5 | 0.227 | 0.407 | 0
|
GID8 | GID complex subunit 8 | 20q13.33 | 0.227 | -0.344 | 3.48e-13
|
EDRF1 | erythroid differentiation regulatory factor 1 | 10q26.2 | 0.226 | -0.322 | 1.15e-11
|
BMPER | BMP binding endothelial regulator | 7p14.3 | 0.226 | 0.355 | 5.07e-14
|
LOC100132287 | | | 0.223 | -0.325 | 7.45e-12
|
C11orf57 | chromosome 11 open reading frame 57 | 11q23.1 | 0.223 | -0.325 | 7.86e-12
|
TRPM6 | transient receptor potential cation channel, subfamily M, member 6 | 9q21.13 | 0.223 | 0.288 | 1.55e-09
|
ZNF343 | zinc finger protein 343 | 20p13 | 0.222 | -0.264 | 3.52e-08
|
EDC3 | enhancer of mRNA decapping 3 | 15q24.1 | 0.222 | -0.361 | 1.61e-14
|
C1orf174 | chromosome 1 open reading frame 174 | 1p36.32 | 0.22 | -0.453 | 0
|
ASXL1 | additional sex combs like transcriptional regulator 1 | 20q11 | 0.216 | -0.278 | 6.31e-09
|
DBF4B | DBF4 zinc finger B | 17q21.31 | 0.216 | -0.426 | 0
|
HBB | hemoglobin, beta | 11p15.5 | 0.215 | 0.417 | 0
|
STARD7 | StAR-related lipid transfer (START) domain containing 7 | 2p11.1 | 0.214 | -0.278 | 6.3e-09
|
MGC16142 | | | 0.21 | -0.334 | 2e-12
|
BORA | bora, aurora kinase A activator | 13q22.1 | 0.208 | -0.43 | 0
|
FOXO1 | forkhead box O1 | 13q14.1 | 0.206 | 0.333 | 2.34e-12
|
SPDYE6 | speedy/RINGO cell cycle regulator family member E6 | 7q22.1 | 0.205 | -0.313 | 4.74e-11
|
SFT2D3 | SFT2 domain containing 3 | 2q14.3 | 0.2 | -0.385 | 2.43e-17
|
LRRC61 | leucine rich repeat containing 61 | 7q36.1 | 0.196 | -0.177 | 0.000248
|
C17orf107 | chromosome 17 open reading frame 107 | 17p13.2 | 0.183 | 0.205 | 2.13e-05
|
ANGEL1 | angel homolog 1 (Drosophila) | 14q24.3 | 0.182 | -0.141 | 0.00348
|